Clinical Research Studies
Since 1997, Cardiology Associates of North MS has been a leader in advancing medical science through clinical research. With a dedicated research department of 9 employees, our cardiologists are investigating new approaches to preventing and treating cardiovascular conditions and diseases. It is through research that medical breakthroughs and better treatment modalities are established. Our clinical research program allows us to make available promising new drug therapies and devices to our patients. Not only does involvement in these studies keep our staff abreast of the latest treatment, but research protocols often provide medication and services to our patients that are not yet available to the general population. We encourage you to consider a research study when appropriate.
Cardiologist Receives FDA Approval for HOCM Treatment
Hypertrophic Obstructive Cardiomyopathy, or HOCM, is a genetic disease in which the septum of the heart is enlarged or thickened. This thickening causes such symptoms as shortness of breath, chest pain, fainting, congestive heart failure, and an abnormal heart beat that can lead to sudden cardiac death. Current treatment to decrease the thickening of the septum in either to surgically remove part of the septum (open heart surgery) or to inject alcohol into a blood vessel to 'kill' part of the septum. The only proven treatment for sudden cardiac death is the implantation of an ICD, or Implantable Cardiac Defibrillator. Cardiology Associates physician, Dr. Karl Crossen, teamed up with Research Manager, Marsha Jones, RN, BSN, CCRP, to write a research protocol for radio-frequency septal ablation, a novel technique in which Dr. Crossen uses radio-frequency to ablate or 'burn' areas of the septum. The procedure does not require invasive surgery or injecting alcohol into blood vessels. After 2 years of working with the FDA (Food and Drug Administration) and the North MS Medical Center, Dr. Crossen and Ms. Jones were granted approval to conduct the research study on 10 patients. On December 12, 2012, Mr. Eugene Ward was the first pt. to have the procedure performed through the research study.
|WHAT’S NEW AT
NMMC HEART INSTITUTE
CANM cardiologists are currently engaged in a diverse assortment of clinical studies investigating new approaches to preventing and treating cardiovascular conditions and diseases. As a result, we are able to offer innovative treatment options and the very latest therapies to our patients. For more information regarding our clinical trials, Click Here.